Clinical UpdatesDrug News

An Indiana company has won temporary court relief from having to provide its employees with coverage for contraceptives and other… »   

For pharmaceutical companies, Africa is changing.

Not only is the continent’s economic growth grabbing attention in boardrooms but the shifting… »   

Irish drugmaker Elan is raising more than $3.25 billion by selling its interests in its main drug and will splash… »   

GlaxoSmithKline plans to cut costs in its struggling European drugs division and promised investors a return to growth this year,… »   

Biogen Idec Inc’s agreement to buy Elan Corp Plc’s interest in the multiple sclerosis drug Tysabri gives Biogen full control… »   

A major trial of a new booster vaccine has ended in failure, marking a major setback in the fight against… »   

Johnson & Johnson may sell or spin off its slow-growing $2 billion-a-year diagnostics business, the company said on Tuesday when… »   

Novartis expects sales to grow in the mid-single digits from 2014 once it has absorbed the full impact of competition… »   

Creditors of the bankrupt pharmacy linked to a deadly U.S. meningitis outbreak are investigating $16 million in salary and shareholder… »   

AstraZeneca’s new chief executive stamped his authority on the struggling drugmaker on Tuesday by removing the heads of research and… »   

A mercury-containing preservative should not be banned as an ingredient in vaccines, U.S. pediatricians said Monday, in a move that… »   

A mercury-containing preservative should not be banned as an ingredient in vaccines, U.S. pediatricians said Monday, in a move that… »   

A new class of drugs reduced the risk of patients contracting a serious and often deadly side effect of lifesaving… »   

Baxter International Inc said on Tuesday it would buy privately held Swedish kidney dialysis product company Gambro AB for about… »   

GlaxoSmithKline expects to have pivotal clinical trial results on up to 14 medicines in the next two years, including two… »